King’s doctor wins health innovator award

Please note that this news items was automatically imported from our old site and may contain formatting errors or broken links.

27 January 2010 - 27January -A novel therapy designed by an Immunologist at King’s College Hospital that could form the basis of a new immunological t...

27January -A novel therapy designed by an Immunologist at King’s College Hospital that could form the basis of a new immunological treatment has been recognised in the ‘NHS London Innovator Awards’.

Dr Mohammad Ibrahim, Consultant and Lead Immunologist at King’s, was victorious in the Pharmaceuticals/Drug Delivery category, which NHS judges admitted was ‘extremely hard fought’.

Dr Ibrahim has developed a new method which uses genetic engineering to combine proteins in order to create a novel therapy. It is hoped the idea could form the basis of a new immunological treatment and/or technology platform for protein drug delivery.

Dr Ibrahim said: “I am honoured our efforts at King’s have been recognised by NHS Innovations London. I hope that our innovation will accelerate development of better drugs to treat chronic inflammatory diseases.”

The award was one of two won by doctors working at King’s Health Partners, one of the UK’s first Academic Health Sciences Centres, which aims to improve patient healthcare by integrating world-class research, clinical care and education and training.

Prof Beverley Hunt, Clinical Lead in Blood Sciences at Guy’s and St Thomas’ NHS Foundation Trust, won the £2,500 award in the ‘Diagnostics/Laboratory’ category. She has developed a test to diagnose antiphospholipid antibodies that can cause blood clots in the arteries and veins and miscarriage in pregnancy. This is based on a finding her team made that blood from patients shows resistance to heparin in the test tube.

Professor Beverly Hunt explains: “I am delighted that our work has been recognised by NHS Innovations London. Being able to better detect antiphospholipid antibodies is crucial to the better management of patients. We hope our work will result in a new diagnostic test that is simple to perform, reliable and cost effective, and will impact on patients with antiphospholipid syndrome, and be transferable across the whole of the UK to increase the quality of patient care.”

Professor Frank Walsh, Director of research and development at King’s Health Partners said: “I am very pleased that my colleagues have received these prestigious awards. Innovation and translation in research is at the heart of King’s Health Partners and these two awards demonstrate real advances. Patients will benefit immediately by having a more accurate diagnosis from Professor Hunt’s work and access to innovative new treatment trials in Dr Ibrahim’s work.”

For further information please contact:
King's Media Team
Extension: +44 (0)20 3299 3257
Fax: +44 (0)20 3299 3207

Notes to editors

Chris Rolfe, Corporate Communications,

King’s College Hospital NHS Foundation Trust.

Tel: 020 3299 3006, Fax: 020 3299 3207


2. King’s College Hospital NHS Foundation Trust is one of the UK’s largest and busiest teaching hospitals, with over 6,500 staff providing around 800,000 patient contacts a year. King’s has a unique profile, with a full range of local hospital services for people in the London boroughs of Lambeth and Southwark as well as specialist services to patients from further afield. The Trust is recognized internationally for its work in liver disease and transplantation, neurosciences, cardiac and haemato-oncology. King’s also plays a key role in the training and education of medical, nursing and dental students with its academic partner, King’s College London. For more information, visit

3. King’s College Hospital NHS Foundation Trust is part of King’s Health Partners Academic Health Sciences Centre (AHSC), a pioneering collaboration between King’s College London, and Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Foundation Trusts.

King’s Health Partners is one of only five AHSCs in the UK and brings together an unrivalled range and depth ofclinical and research expertise, spanningboth physical and mental health. Our combined strengths will drive improvements in care for patients, allowing them to benefit from breakthroughs in medical science and receive leading edge treatment at the earliest possible opportunity.

For more information, visit